on FERMENTALG (EPA:FALG)
Fermentalg Reports 41% Sales Growth in Q3 2026
Fermentalg, a company specialized in developing natural Biosolutions, announced a significant acceleration in sales for the 3rd quarter of 2026. The company's revenue reached €2.9 million, marking a 41% increase compared to the same period in the previous year.
The growth was strongly influenced by the success of the ΩRIGINSTM lipid range in high-value segments such as food supplements and infant nutrition, which saw a 34% increase over the first nine months of the year. Sales in these sectors now represent more than a third of Fermentalg's total sales.
Despite a 60% decline in the aquaculture market, Fermentalg is optimistic about reaching €5 million in revenue for the 4th quarter. This optimism is contingent on the successful industrial scaling of their natural blue colorant, Galdieria BlueTM.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all FERMENTALG news